comparemela.com

Latest Breaking News On - Samuelu takvorian - Page 1 : comparemela.com

Dr Takvorian on the Evolution of PARP Inhibitors in Prostate Cancer

Samuel U. Takvorian, MD, MS, discusses the evolution of regulatory decisions regarding the use of PARP inhibitors for patients with prostate cancer.

ASCO 2023: Payment Models and Policy

Coverage of ASCO sessions and posters that addressed lessons from the Oncology Care Model and concerns about the Enhancing Oncology Model, which launched shortly after the annual meeting ended.

Poster Talks Explore How Policy, Payer Incentives Affect Cancer Care, Outcomes

Insurers Pay More for Cancer Surgery at NCI Centers—Is It Worth It?

Insurers Pay More for Cancer Surgery at NCI Centers—Is It Worth It?
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.